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Abstract
The additive, ‘Zinc-L-selenomethionine’ (Zn-L-SeMet) is intended to be used as a source of selenium for
all animal species. The applicant intends to market the active compound blended with inert carriers
(Availa®Se). Zn-L-SeMet is a safe source of selenium for chickens for fattening; the conclusion is
extended to all animal species. Selenium from Zn-L-SeMet does not elicit any adverse effects not
expected for a selenium compound. The use of Zn-L-SeMet in animal nutrition is expected to result in a
similar increase in selenium deposition in animal tissues/products as that resulting from other sources
of SeMet. The use of the additive up to the maximum selenium supplementation level established for
other sources of organic selenium (0.2 mg/kg complete feed) and complying with the maximum
authorised total selenium content is safe for consumers. The additive is hazardous upon inhalation;
owing to the high dusting potential, persons handling Availa®Se are at risk by inhalation. Availa®Se is
not an irritant to the skin. In the absence of data, no conclusion on the eye irritation and skin
sensitisation can be drawn. The use of Zn-L-SeMet in feed does not pose an additional risk to the
environment, compared with other sources of selenium for which it will substitute, as long as the
maximum authorised content in complete feed is not exceeded. Zn-L-SeMet is an effective source of
selenium in chickens for fattening and laying hens; this conclusion is extended to all animal species.
The maximum contribution of zinc in total feed deriving from the use of the additive (< 0.2 mg Zn/kg
feed) is considered low and does not need any safety assessment except for users.
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Summary
Following a request from the European Commission, the Panel on Additives and Products or
Substances used in Animal Feed (FEEDAP) was asked to deliver a scientiﬁc opinion on safety and
efﬁcacy of zinc-L-selenomethionine (Zn-L-SeMet) for all animal species.
The additive, ‘Zinc-L-selenomethionine’ (Zn-L-SeMet) is intended to be used as a source of selenium
for all animal species. The preparation to be marketed is a blend of the active compound with inert
carriers (in this assessment called as ‘formulated additive’; trade name: Availa®Se).
Conclusions on the safety of an additive for target species are generally based on the absence of
adverse effects in a tolerance study. No such effects were seen (i) in the zootechnical endpoints for
the additive under assessment and the already authorised inorganic sodium selenite, also by
comparison with the unsupplemented control diet and (ii) in most haematology and serum
biochemistry parameters (the few exceptions were of statistical nature as well as unclear biological
relevance, if any). The response of selenium serum levels and glutathione peroxidase (GPx) activity to
dietary Zn-L-SeMet indicates selenium bioavailability. It is therefore concluded that the Zn-L-SeMet is a
safe source of selenium for chickens for fattening. The conclusion is extended to all animal species.
Selenium from Zn-L-SeMet does not elicit any adverse effects not expected for a selenium
compound. The use of Zn-L-SeMet in animal nutrition is expected to result in a similar increase in
selenium deposition in animal tissues/products as that resulting from other sources of SeMet. The use
of the additive is safe for consumers provided that the maximum selenium supplementation level
established for other sources of organic selenium (0.2 mg/kg complete feed) and that the maximum
authorised total selenium content (0.5 mg/kg complete feed) are respected.
The additive is hazardous upon inhalation; owing to the high dusting potential, persons handling
Availa®Se are at risk by inhalation. Availa®Se is not an irritant to the skin. In the absence of data, no
conclusion on the eye irritation and skin sensitisation can be drawn.
The use of Zn-L-SeMet in feed does not pose an additional risk to the environment, compared with
other sources of selenium for which it will substitute, as long as the maximum authorised content in
complete feed is not exceeded.
Zn-L-SeMet is an effective source of selenium in chickens for fattening and laying hens; this
conclusion is extended to all animal species.
The maximum contribution of zinc in total feed deriving from the use of the additive (< 0.2 mg Zn/kg
feed) is considered low and does not need any safety assessment except for users.
The FEEDAP Panel recommends to use the additive in compound feed via premixtures.
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1. Introduction
1.1. Background and Terms of Reference
Regulation (EC) No 1831/20031 establishes the rules governing the Community authorisation of
additives for use in animal nutrition. In particular, Article 4(1) of that Regulation lays down that any
person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an
application in accordance with Article 7.
The European Commission received a request from Zinpro Animal Nutrition (Europe), Inc.2 for
authorisation of the product zinc L-selenomethionine, when used as a feed additive for all animal
species (category: nutritional additives; functional group: compounds of trace elements).
According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the
application to the European Food Safety Authority (EFSA) as an application under Article 4(1)
(authorisation of a feed additive or new use of a feed additive). EFSA received directly from the
applicant the technical dossier in support of this application. The particulars and documents in support
of the application were considered valid by EFSA as of 24 October 2016.
According to Article 8 of Regulation (EC) No 1831/2003, EFSA, after verifying the particulars and
documents submitted by the applicant, shall undertake an assessment in order to determine whether
the feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on
the safety for the target animals, consumer, user and the environment and on the efﬁcacy of the
product zinc L-selenomethionine, when used under the proposed conditions of use (see Section 3.1.6).
1.2. Additional information
Zinc-L-selenomethionine (Zn-L-SeMet) is intended to be used as a source of selenium for all animal
species. The additive has not been previously authorised as a feed additive in the European Union (EU).
The applicant holds a patent on the Zn-L-SeMet, with the title ‘Derivatives of seleno-amino acids
with improved bioavailability and method for assuring adequate dietary requirements of selenium for
livestock’.3 The primary objective of the invention was the development of new compounds intended to
enhance the bioavailability and/or increase the stability of seleno-amino acids.
In 2014, the Food and Drug Administration (FDA) announced that Zinpro Corp. ﬁled a petition
proposing that the food additive regulations be amended to provide for the safe use of Zn-L-SeMet as
a source of selenium in complete feed for broiler chickens.4
2. Data and methodologies
2.1. Data
The present assessment is based on data submitted by the applicant in the form of a technical
dossier5 in support of the authorisation request for the use of Zn-L-SeMet as a feed additive for all
animal species. The technical dossier was prepared following the provisions of Article 7 of Regulation
(EC) No 1831/2003, Regulation (EC) No 429/20086 and the applicable EFSA guidance documents.
The FEEDAP Panel used the data provided by the applicant together with data from other sources,
such as previous risk assessments by EFSA or other expert bodies, peer-reviewed scientiﬁc papers and
other scientiﬁc reports, to deliver the present output.
EFSA has veriﬁed the EURL report as it relates to the methods used for the control of Zn-L-SeMet in
animal feed. The Executive Summary of the EURL report can be found in Annex A.7
1 Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in
animal nutrition. OJ L 268, 18.10.2003, p. 29.
2 Zinpro Animal Nutrition (Europe), Inc. Akkerdistel 2E. 5831 PJ. Boxmeer. The Netherlands.
3 Patent number EP 1594365 A1. The primary objective of the invention was the development of new compounds intended to
enhance the bioavailability and/or increase the stability of seleno-amino acids. Available online: https://www.google.com/patents/
EP1594365A1?cl=en
4 https://www.federalregister.gov/documents/2014/08/21/2014-19831/zinpro-corp-ﬁling-of-food-additive-petition-animal-use
5 FEED dossier reference: FAD-2016-0056.
6 Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation (EC)
No 1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of applications
and the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008, p. 1.
7 The full report is available on the EURL website: https://ec.europa.eu/jrc/sites/jrcsh/files/ﬁnrep-fad-2016-0056-zinc-selenome
thionine.pdf
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2.2. Methodologies
The approach followed by the FEEDAP Panel to assess the safety and the efﬁcacy of Zn-L-Se-Met is
in line with the principles laid down in Regulation (EC) No 429/20086 and the relevant guidance
documents: Guidance on nutritional additives (EFSA FEEDAP Panel, 2012a), Technical guidance:
Tolerance and efﬁcacy studies in target animals (EFSA FEEDAP Panel, 2011a), Technical Guidance for
assessing the safety of feed additives for the environment (EFSA, 2008), Guidance for establishing the
safety of additives for the consumer (EFSA FEEDAP Panel, 2012b) and Guidance on studies concerning
the safety of use of the additive for users/workers (EFSA FEEDAP Panel, 2012c).
3. Assessment
The active compound under assessment is the Zn-L-SeMet. The preparation to be marketed is a blend
of the active compound with inert carriers (in this assessment called as ‘formulated additive’; trade name:
Availa®Se 1000). It is intended to supply selenium as nutritional element to all animal species.
3.1. Characterisation
3.1.1. Characterisation of the compound
The additive is ‘Zinc-L-Selenomethionine’. Another generic international name is also (S)-(+)-2-
amino-4-(methylseleno)butanoic acid. It has neither a Chemical Abstracts Service (CAS) number nor an
International Union of Pure and Applied Chemistry (IUPAC) name. Its chemical formula is
C5H10ClNO2SeZn, the structural formula is shown in Figure 1 and it has a molecular weight of
295.94 Da. The theoretical content of selenium is 26.7% and of zinc of 22.1%.
The molecular structure of the active compound was characterised in three lots by infrared and
proton nuclear magnetic resonance spectroscopies.8
The active compound is not available from the synthesis as such (puriﬁed), but together with
hydrochloric acid (see Section 3.1.3). Five batches of the reaction product were analysed for
selenomethionine (SeMet), total selenium, zinc and chloride.9 The average content of SeMet was about
63.6%, selenium 25.6%, zinc 20% and chloride 21.3%
The same ﬁve batches were analysed for undesirable substances.10 Levels of heavy metals
(Cd < 1 mg/kg compound11; Pb < 1 mg/kg compound;8 Hg < 0.1 mg/kg compound), F (< 25 mg/kg
compound) and As (< 1 mg/kg compound) were reported. The levels of dioxins and the sum of dioxins
and dioxin-like PCBs were 0.13–0.18 ng WHO-PCDD/F-TEQ/kg and 0.18–0.23 ng WHO-PCDD/F-PCB-
TEQ/kg, respectively. The concentrations of the undesirable substances analysed comply with those set
in Directive 2002/32/EC12 for compounds of trace elements or, if not mentioned in the Directive, do
not represent a concern.
Figure 1: Structural Formula of zinc-L-selenomethionine (taken from Zinpro Patent Number EP
1594365 A1)
8 Technical Dossier/Section II.
9 Technical Dossier/Section II/Annexes II-32 to II-36.
10 Technical Dossier/Section II/Annexes II-37 to II-41.
11 These values are not consistent with the limit of quantiﬁcation of the analytical method (LOQ: 0.1 mg/kg). Technical Dossier/
Supplementary information.
12 Directive 2002/32/EC of the European Parliament and of the Council of 7 May 2002 on undesirable substances in animal feed.
OJ L 140, 30.5.2002, p. 10.
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3.1.2. Characterisation of the formulated additive
The formulated additive is a solid preparation with a light grey to tan colour and no odour. The
relative density is 2.9. It is very slightly soluble in water.13 The bulk density, measured in three
samples, ranged between 1.39 and 1.41 g/cm3.
As formulated, Zn-L-SeMet provides a minimum of selenium and SeMet of 1,000 and 2,500 mg/kg
additive, respectively.
The composition of the formulated additive is: 97.0% of calcium carbonate, 1.62% of silicon
dioxide, 1.02% of vegetable oil and 0.36% of Zn-L-SeMet.
Five batches of the formulated additive were analysed for zinc, selenium and SeMet.14 Zinc content
ranged from 875 to 910 mg/kg; total selenium content from 1,041 to 1,157 and SeMet from 2,530 to
2,751 mg/kg, thus meeting the speciﬁcations. The ratio between zinc and selenium is about 0.82.
Six batches were analysed for undesirable substances, except for ﬂuorine in which results for
only four batches were reported.15 Levels of heavy metals (Cd: 0.16 to < 1 mg/kg additive16; Pb:
1.18–2.17 mg/kg additive; Hg: < 0.05–< 0.1 mg/kg additive),13 F (16.6–66.5 mg/kg additive13) and
As (< 0.1–1.16 mg/kg additive) were reported. The levels of dioxins and the sum of dioxins and
dioxin-like PCBs were 0.044–0.089 ng WHO-PCDD/F-TEQ per kg and 0.10–0.14 ng WHO-PCDD/
F-PCB-TEQ per kg, respectively. The concentrations of the undesirable substances analysed comply
with those set in Directive 2002/32/EC for compounds of trace elements or, if not mentioned in the
Directive, do not represent a concern.
Analysis of ﬁve batches (aged from 2 weeks to 10 months) conﬁrmed the absence of microbial
contamination. Counts of Enterobacteriaceae, moulds and yeasts were below the limit of quantiﬁcation
(LOQ) (< 10 cfu/g); Salmonella was not detected in 25 g.17 Levels of aﬂatoxin B1 and ochratoxin A
analysed in three batches were below the LOQ (4 lg/kg).18,19
Analysis of the particle size distribution (v/v) by laser diffraction (three batches) showed that 1.1–4.1%
of the particles had a diameter < 10 lm, 3.2–12.4% < 50 lm and 13.1–27.2% < 100 lm.20
Dusting potential was analysed in three batches by the Stauber–Heubach method (four
measurements of each batch).21 The values reported were in the range of 6.1–11.0 g/m3. The same
batches were submitted for analysis of the particle size and the zinc and selenium content (two
measurements per batch) of the dust.22 The results showed that on average 93% of the particles were
below 10 lm; zinc ranged from 3,458 to 7,901 mg/kg dust23 and selenium from 3,307 to 5,833 mg/kg
dust. These data show that there is an enrichment of the zinc and selenium in the dust compared with
the additive, likely due to the ﬁner particles in the active compound compared to the other
components of the additive.
3.1.3. Manufacturing process24
The additive is produced by complexing L-SeMet (from chemical synthesis)19 with zinc to form Zn-L-
SeMet complex. The manufacturing process of the active compound and of the formulated additive are
described in the technical dossier.
3.1.4. Stability and homogeneity
For compounds of trace elements, stability studies are generally not required. The applicant
proposed for the formulated additive a shelf-life of 24 months. Two stability studies with three batches
each under ambient (25°C/60% relative humidity (RH)) and accelerated (40°C/75% RH) conditions
13 Technical Dossier/Section II/Annex II-53.
14 Dossier/Section II/Annexes II-1 to II-5.
15 Technical Dossier/Section II/Annexes II-10 to II-15.
16 Assuming that the LOQs for the analysis of undesirable substances in the additive are the same as those for the active
compound (see footnote 8), these values are found not to be consistent with a LOQ of 0.1 mg/kg for Cd and Hg and of
25 mg/kg for F.
17 Technical Dossier/Section II/Annexes II-21 to II-25.
18 Technical Dossier/Section II/Annexes II-26 to II-28.
19 Technical Dossier/Supplementary information.
20 Technical Dossier/Section II/Annex II-29.
21 Technical Dossier/Section II/Annex II-30.
22 Technical Dossier/Section II/Annex II-31.
23 Zinc in one batch was not determined.
24 This section has been amended following the conﬁdentiality claims made by the applicant.
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were on-going at the time of the assessment, monitoring SeMet content.25 Only values up to 3 months
were made available. The SeMet content decreased after 3 months storage under ambient conditions
from 3,370 to 3,073 mg (91.2%) and under accelerated conditions to 2,763 mg (82.0%) per kg
formulated additive.
A stability study of the additive in premixtures and mash feed monitoring selenium was provided.26
This study is part of the efﬁcacy study submitted (see also Section 3.3.1). After about 9 months of
storage, a recovery of 98.5% and 93.3% was reported for premixture and mash feed, respectively.
The FEEDAP Panel notes that in this study the identiﬁed main active substance, i.e. SeMet, was not
quantiﬁed.
The capacity of the additive to homogeneously distribute in premixtures27 and complete feed (mash
and pelleted)28 was investigated, analysing the selenium content in 10 subsamples each. The
coefﬁcient of variation (CV) of the selenium concentration in the premixture (mean 289 mg/kg) was
7.4%. The CV of the mash feed (mean selenium content: 0.195 mg/kg) was 3.0%, that of the same
feed after pelleting 3.3%.
3.1.5. Physicochemical incompatibilities or interactions
No incompatibilities resulting from the use of Zn-L-SeMet in compound feed are expected with the
feed materials, carriers, other approved additives or medicinal products.
3.1.6. Conditions of use
The additive is intended to be used in feed for all animal species. It should be used up to a
maximum supplementation rate of 0.2 mg Se/kg feed; a total selenium concentration of 0.5 mg/kg
feed should not be exceeded. The additive should be incorporated to feed via a premixture.
3.2. Safety
3.2.1. Absorption, distribution, metabolism and excretion (ADME)
No speciﬁc studies on the toxicokinetics of Zn-L-SeMet were provided. It can reasonably be
assumed that the zinc moiety is dissociated in the intestine (see also Section 3.3). Taking into account
the conditions of use of the additive, the content of zinc is negligible and will not be further considered
(see also Section 3.1.6).29 Consequently, SeMet is the only relevant fraction. The ADME of L-SeMet,
including its hydroxy-analogue and the DL-form, has been described in previous EFSA FEEDAP opinions
(EFSA, 2006, 2009; EFSA FEEDAP Panel, 2011b,c; EFSA FEEDAP Panel, 2013a,b, 2014a). Ingested
SeMet is actively absorbed in the gut like methionine, the sulfur analogue of SeMet (Schrauzer, 2000);
a common Na+ dependent transport mechanism of SeMet and Met in the jejunal brush border
membrane of pigs was shown as early as in 1989 (Wolffram et al., 1989); rapid distribution of the
absorbed SeMet occurs in most organs (Alexander, 2015). SeMet is non-speciﬁcally incorporated into
body proteins as a substitute for the common amino acid Met (Schrauzer, 2000); it can act as a
selenium reservoir for the organism. Another portion of SeMet is metabolised resulting into dihydrogen
selenide to be utilised in selenium pathways. Urine is the major excretory pathway of selenium
(Alexander, 2015).
3.2.2. Toxicological studies
No speciﬁc toxicological studies for the product under assessment were provided by the applicant.
Considering the contribution of zinc by the highest supplementation of the additive, any exposure
from zinc from the additive is considered toxicologically negligible. The Met from the additive will be
incorporated in body proteins or completely metabolised (EFSA FEEDAP Panel, 2012d). Both
components are therefore not considered a toxicological concern.
The toxicology of selenium, including organic forms, namely SeMet, has been extensively reviewed
by the Scientiﬁc Committee on Food (SCF) (European Commission, 2000), the Agency for Toxic
25 Technical Dossier/Section II/Annexes II-48 and II-49.
26 Technical Dossier/Section II/Annex II-50.
27 Technical Dossier/Section II/Annex II-51.
28 Technical Dossier/Section II/Annex II-52.
29 Considering the maximum supplementation rate of the formulated additive (i.e. 200 mg Availa®Se 1,000 per kg complete
feed), the contribution of zinc from the additive to the total dietary zinc would be below 0.2 mg/kg.
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Substances and Disease Registry (ATSDR, 2003), the WHO (2011), the European Medicines Agency
(EMA, 2015) and the FEEDAP Panel (EFSA, 2006, 2009; EFSA FEEDAP Panel, 2011b,c, 2013a,b, 2014a,b,
2015, 2016a,b).
Brieﬂy, selenium excess (selenosis) is a well-known disease in humans and animals. Although
selenium may induce oxidative DNA damage in vitro, genotoxic effects could be shown in vivo only when
toxic doses (> 3 mg Se/kg body weight (bw)) were applied (European Commission, 2000). Teratogenic
effects occur at high doses in birds (> 3 mg Se (as SeMet)/kg diet; Spallholz and Hoffman, 2002) and
ﬁshes (> 10 mg Se/kg diet; Lemly, 2002); however, developmental toxicity in mammals is controversial
(EMA, 2015). Endocrine-disrupting effects targeting thyroid, growth hormone and insulin-like growth
factor, have been described in humans (Maggio et al., 2010; Valdiglesias et al., 2010) and in mice (Ren
et al., 2016); however, such effects are reversible in adult individuals upon discontinuation of exposure.
The FEEDAP Panel considers that selenium supplementation using the additive Zn-L-SeMet does not
introduce any different toxicological concerns compared to other organic sources of selenium.
3.2.3. Safety for the target species
3.2.3.1. Safety for target species
Where a feed additive application is made as a nutritional additive for all animal species, tolerance
data may be limited to one species. The applicant provided a tolerance study with Zn-L-SeMet
(Availa®Se) in chickens for fattening with duration of 36 days.30,31
A total of 1,200 one-day-old male broiler chickens (Ross 308) were allocated to ﬁve treatment
groups in a randomised complete block design. Each treatment had 12 replicates (pens) containing 20
birds each. The treatments consisted of a negative control (starter and grower feeds containing 0.04
and 0.07 mg Se/kg, respectively), two groups with added sodium selenite (0.2 and 2.0 mg Se/kg) and
two treatments with added Zn-L-SeMet (0.2 and 2.0 mg Se/kg). The birds did not receive any medical
treatment during the trial.
All chickens were fed ad libitum a pelleted feed (starter/grower). The diets were mainly composed
of wheat, maize and soybean meal and contained as a starter (day 1–21) 21.0% crude protein (CP)
and 12.1 MJ AME/kg and as grower (from day 22 onwards) 19.6% CP and 12.5 MJ AME/kg. Final
feeds were analysed for nutritional composition, energy and selenium concentration.
The birds were inspected at least once a day for general health. Mortality was daily monitored.
Body weight was measured at the end of the starter period (day 21) and at the end of the study (day
36), feed intake was recorded for both periods. Body weight gain and feed to gain ratio were
calculated for the corresponding intervals. Blood samples were taken from two birds per pen on day
36 (haematology,32 clinical biochemistry33) and on day 37 (selenium, glutathione peroxidase (GPx) for
the treatments without selenium supplementation and with 0.2 mg Se from both sources/kg feed).
GPx was analysed on the individual samples, selenium on pooled pen samples. The birds used for
blood collection on day 36 were subsequently killed; samples of liver, kidney, muscle tissue (left breast)
and skin plus fat of the control group and of the groups with feed supplemented with 0.2 mg Se/kg
were taken for tissue analysis (pooled samples per pen). Neither macroscopic nor microscopic
examination of organs and tissues was made at necropsy.
The data were subjected to analysis of variance (ANOVA) considering blocks and treatments as
variables. Treatments were compared by the least signiﬁcant differences (LSD) test after signiﬁcant
effects had been conﬁrmed by ANOVA. Differences with a p value ≤ 0.05 were considered signiﬁcant,
based on a two-sided test. The pen was the statistical unit for the zootechnical parameters and the
pooled selenium levels in serum and tissues, and the individual bird for other blood parameters.
No adverse health effects were seen. At the end of the study, there were no signiﬁcant differences
between the groups for body weight gain, feed to gain ratio and mortality (Table 1). The
haematological endpoints were not signiﬁcantly different (except the monocytes, which were lower at
the 0.2 mg Se from Zn-L-Se-Met than for all other groups; Table 2). Concerning blood biochemistry,
the only signiﬁcant differences were seen for alkaline phosphatase (ALP) and calcium (see Table 2). ALP
30 Technical Dossier/Section III/Annex III_1.
31 Some animals were kept for 37 days.
32 Red blood cells, packed cell volume, haemoglobin, white blood cell, lymphocytes, neutrophil granulocytes, monocytes, mean
corpuscular haemoglobin, mean corpuscular haemoglobin concentration, mean corpuscular volume.
33 Albumin, albumin/globulin ratio, total protein, alkaline phosphatase, alanine aminotransferase, aspartate aminotransferase,
lactate dehydrogenase, gamma-glutamyl transferase, glutamate dehydrogenase, creatinine, creatine phosphokinase, bilirubin,
glucose, triglycerides, cholesterol, urea, Ca, P, K, Na, Cl.
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increased in the Zn-L-SeMet groups, the value for the high dose being signiﬁcantly different to the
control; both selenite groups did not differ from the control. Calcium was signiﬁcantly higher in the high
selenium Zn-L-SeMet group compared to the two 0.2 mg Se/kg groups. The GPx levels in serum were
signiﬁcantly higher in the two selenium supplemented groups (only the 0.2 mg Se supplementation
groups analysed) without differences between the selenium sources. The supplemented birds had a 30
fold increase in GPx activity, whereas the increase in serum selenium was only ﬁve- to sixfold (see
Section 3.3). Selenium in serum was highest in the Zn-L-SeMet group, followed by the sodium selenite
group with lowest levels in the control group. GPx activity is considered as a biomarker of selenium
bioavailability, and the observed increase, together with elevated selenium serum levels, indicates
selenium bioavailability from Zn-L-SeMet. The few other differences seen in haematology and serum
biochemistry parameters were, if any, of unclear biological relevance.
3.2.3.2. Conclusions on safety for the target species
Conclusions on the safety of an additive for target species are generally based on the absence of
adverse effects in a tolerance study. No such effects were seen (i) in the zootechnical endpoints for
the additive under assessment and the already authorised inorganic sodium selenite, also by
comparison with the unsupplemented control diet and (ii) in most haematology and serum
biochemistry parameters (the few exceptions were of statistical nature as well as unclear biological
relevance, if any). The response of selenium serum levels and GPx activity to dietary Zn-L-SeMet
indicates selenium bioavailability. It is therefore concluded that the Zn-L-SeMet is a safe source of
selenium for chickens for fattening. The conclusion is extended to all animal species.
3.2.4. Safety for the consumer
3.2.4.1. Deposition studies
Deposition data in tissues and eggs were taken from the tolerance study in chickens for fattening
(described in Section 3.2.3.1) and from an efﬁcacy study in laying hens (described in Section 3.3.2).
Table 1: Effects of various dosages of sodium selenite and zinc-L-selenomethionine (AvailaSe) on
performance of chickens for fattening (day 36) (240 birds per treatment)
Selenium supplemented (mg/kg)
0
Na-selenite Availa®Se
0.2 2.0 0.2 2.0
Selenium content(1)
Starter diet 0.04 0.23 2.04 0.29 2.26
Grower diet 0.07 0.27 2.13 0.33 2.51
Mortality (%) 4.6 4.6 5.7 3.4 8.4
Feed intake (g/bird) 3,847ab 3,834ab 3,753a 3,914b 3,800a
Body weight gain (g/bird) 2,683 2,734 2,661 2,782 2,730
Feed to gain ratio (kg/kg) 1.434 1.403 1.412 1.407 1.392
(1): Analysed (mg/kg).
a,b: Different superscripts within a given row indicate statistical differences (p < 0.05).
Table 2: Effects of various dosages of sodium selenite and zinc-L-selenomethionine (AvailaSe) on
haematology and biochemistry parameters of chickens for fattening (day 36) (24 birds per
treatment)
Selenium supplemented
(mg/kg) 0
Na-selenite AvailaSe
0.2 2.0 0.2 2.0
Monocytes (109/L) 0.09b 0.07ab 0.09b 0.02a 0.10b
Alkaline phosphatase (IU/L) 4,951ab 4,920ab 4,416a 6,142bc 7,252c
Calcium (mmol/L) 2.59b 2.45a 2.49ab 2.45a 2.60b
Glutathione peroxidase in
serum (U/mL)
48a 1,448b ND(1) 1,414b ND
(1): ND: Not Determined.
a,b,c: Different superscripts within a given row indicate statistical differences (p < 0.05).
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Results of the negative control, the group with sodium selenite at 0.2 mg/kg and the group with
Zn-L-SeMet at 0.2 mg/kg are reported in Table 3.
There were signiﬁcant effects of selenium level and source on the selenium content of the four
tissues examined and eggs. In chickens for fattening, the negative control had signiﬁcantly lower
selenium levels in liver, kidney and skin than the standard sodium selenite treatment, which in turn had
signiﬁcantly lower selenium levels than the standard Zn-L-SeMet treatment. The selenium levels in
breast muscle were not different between the negative control and the standard sodium selenite
treatment, but both were signiﬁcantly lower than the Zn-L-SeMet treatment.
In both deposition studies performed on chickens for fattening or on laying hens, the level of
selenium is higher in the tissues and products in the Zn-L-SeMet treatment compared to control
treatment or to sodium selenite treatment.
3.2.4.2. Assessment of the safety for the consumer
The upper tolerable level (UL) for selenium has been set by the Scientiﬁc Committee on Food
(European Commission, 2000) (adults: 300 lg/day; toddlers: 60 lg/day), and used by the FEEDAP
Panel in previous assessments of the consumer safety for different selenium compounds.
Data provided by the applicant showed increased tissue deposition of selenium from dietary Zn-L-
SeMet compared with sodium selenite (see Table 3). The FEEDAP Panel has several times expressed its
view that SeMet yeast sources would result in similar selenium deposition (EFSA FEEDAP Panel, 2011b,c,
2012e); this view was later extended to the hydroxy-analogue of SeMet (HMSeBA) (EFSA FEEDAP Panel,
2013a), to L-SeMet (EFSA FEEDAP Panel, 2013b) and to DL-SeMet (EFSA FEEDAP Panel, 2014a). There is
no reason to assume that SeMet from different sources would result in an essentially different deposition
pattern in edible tissues/products.
The FEEDAP Panel has previously concluded that the selenium supplementation of feed by
selenised yeast, by HMSeBA, by L-SeMet or by DL-SeMet should be limited to a maximum of 0.2 mg
Se/kg feed. Therefore, with respect to consumer safety, the Panel concludes that supplemental
selenium from Zn- L-SeMet should equally be limited to a maximum of 0.2 mg/kg feed.
3.2.4.3. Conclusions on safety for the consumer
The use of Zn-L-SeMet in animal nutrition is expected to result in a similar increase in selenium
deposition in animal tissues/products as that resulting from other sources of SeMet. To ensure
consumer safety from consumption of food originating from animals fed Zn-L-SeMet, the FEEDAP
Panel concludes that dietary selenium supplementation from the additive should not exceed a
maximum of 0.2 mg/kg complete feed, within the maximum total selenium content of 0.5 mg/kg
authorised in the EU for complete feedingstuffs.
Table 3: Data on tissue and egg deposition of sodium selenite and zinc-L-selenomethionine
(AvailaSe) from a study in chickens for fattening (day 36) (24 birds per treatment) and a
study in laying hens (day 59)
Selenium supplemented (mg/kg)
0
Na-selenite Availa®Se Ratio Se from
Availa®Se to Se
from Na-selenite0.2 0.2
Selenium content in:
Breast muscle (ng/g) 100a 103a 265b 2.57
Liver (ng/g) 250a 513b 655c 1.27
Kidney (ng/g) 253a 695b 809c 1.16
Skin/fat (ng/g) 79a 159b 232c 1.46
Egg (ng/g liquid egg)(1) < 50(2) 129a 231b 1.79
(1): From the Efﬁcacy study (see also Section 3.3.2).
(2): Corresponds to LOQ.
a,b,c: Different superscripts within a given row indicate statistical differences (p < 0.05).
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3.2.5. Safety for the user
3.2.5.1. Effects on the respiratory system
No speciﬁc inhalation toxicity studies for the product under assessment were provided by the
applicant.
However, due to the high dusting potential of the formulated additive (maximum determined:
11.0 g/m3), an estimation of inhalation exposure was performed.
Taking in consideration the selenium content in dust (average concentration of 4,777 mg/kg), it can
therefore be expected that 52.5 mg Se/m3 (11.0 g dust/m3 9 4,777 mg/kg) will be the selenium
content in the dust. The respirable fraction could be estimated to be 93% (see Section 3.1.2). Thus,
the selenium concentration in the respirable dust would then be 49 mg/m3 (93% 9 52.5 mg Se/m3).
Following the above-described approach for zinc, a value of 59 mg Zn/m3 is estimated in the
respirable dust.
The estimated value for selenium and for zinc exceeds, respectively, by 3 and by 1 orders of
magnitude the most recent internationally accepted proposed thresholds for selenium (0.02 mg/m3,
set by the Deutsche Forschungsgemeinschaft as maximum concentration in the workplace (Maximale
Arbeitsplatz Konzentration, MAK) (DFG, 2012)) and for zinc (2 mg/m3, set by the American Conference
of Governmental Industrial Hygienists as threshold limit value (TLV) (ACGIH, 2003), respectively.
Consequently, the FEEDAP Panel considers that the additive poses a risk upon inhalation to users.
3.2.5.2. Effects on the eyes and skin
The applicant submitted an acute skin irritation assay in the rabbit, performed with the formulated
additive according to the OECD Guidance 404.34 Availa®Se was found to be non-irritant for the skin of
the rabbit.
No speciﬁc studies on eye irritation and skin sensitisation were submitted.
3.2.5.3. Conclusions on safety for the user
The additive is hazardous upon inhalation. Owing to the high dusting potential, persons handling
Availa®Se are at risk by inhalation.
Availa®Se is not an irritant to the skin. In the absence of data, no conclusion on the eye irritation
and skin sensitisation can be drawn.
3.2.6. Safety for the environment
It is well documented in the scientiﬁc literature that, owing to the speciﬁc metabolic fate of organic
selenium compounds, which reasonably include the Zn-L-SeMet, signiﬁcantly more selenium from
organic sources than from inorganic sources is retained in the animal body (see Section 3.2.4.1,
Table 3), and therefore less selenium is expected to be released to the environment.
Therefore, the FEEDAP Panel considers that the use of Zn-L-SeMet in feed does not pose an
additional risk to the environment, compared with other sources of selenium for which it will
substitute, as long as the maximum authorised content in complete feed is not exceeded. Moreover,
the maximum permitted selenium supplementation from organic selenium sources is about half of that
for inorganic sources.
Since the contribution of zinc from the additive will be negligible (see also Section 3.2.1), the
environmental impact of zinc needs not to be addressed.
3.3. Efﬁcacy
For demonstration of the efﬁcacy of nutritional additives, one study in a single animal species or
category, including laboratory animals, is considered sufﬁcient. Zn-L-SeMet is a compound of trace
elements not already authorised as a feed additive, a short-term study is required by to support
efﬁcacy (Commission Regulation (EC) No 429/2008; EFSA FEEDAP Panel, 2012a).
The applicant made for that purpose reference to the studies provided to investigate safety of the
additive in chickens for fattening and selenium deposition in chicken and eggs (see also Section 3.2.4).
Also, a third study published by Chantiratikul et al. (2008a,b) could be considered for that purpose.
34 Technical Dossier/Section III/Annex_III_3.
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3.3.1. Study in chickens for fattening
The study has been described above (see Section 3.2.3.1). The results of this study clearly indicate
that at the highest use level of selenium (0.2 mg/kg) from Zn-L-Se-Met (i) selenium is absorbed, serum
selenium increased from 29 in the unsupplemented control to 172 ng/mL, (ii) selenium is deposited in
tissues and organs (see Table 3) and (iii) selenium is incorporated into the functional enzyme GPx
(increase in serum from 48 to 1,414 U/mL (see Table 2)).
3.3.2. Studies in laying hens
After a preperiod of 42 days on a basal diet without selenium supplementation, a total of 180
HyLine Brown laying hens (23-week-old, mean body weight: 1,728 g) were distributed to ﬁve
treatments with 12 replicates each.35 The replicate was a cage with three hens. The treatments were
(i) no selenium supplementation (basal diet), (ii) supplementation of 0.2 and 0.3 mg Se/kg from
Na-selenite (concentrations conﬁrmed by analysis) and (iii) supplementation of 0.2 and 0.3 mg Se/kg
from Zn-L-SeMet. These diets (mash maize soybean meal type diet with 14.8% CP, 12.5% ash, and
11.4 MJ ME/kg) were fed for 60 days.
Performance (body weight, feed intake, feed to egg ratio, egg production) was assessed at day 28
and day 59 while eggs (all eggs pooled/replicate) and blood samples (2 hens/replicate) for analysis of
Se and GPx (serum only) were collected on day 59 and day 60 for backup samples. Statistical
examination was done by ANOVA (mixed models, Tukey adjustment), differences with a p < 0.05 were
considered signiﬁcant.
The main results are summarised in Table 4. No deaths occurred during the study. No signiﬁcant
differences were seen for the performance parameters, except for the ratio feed to egg mass for which an
increase was found in the highest dose of Na-selenite. The Panel suggests that the number of hens per
group was not high enough and that the study duration (and that of the depletion period) was not long
enough to detect effects on performance by the addition of selenium to a Se-deﬁcient diet.
The selenium levels analysed in serum and egg reﬂected the dietary selenium concentration.
Selenium deposition in the liquid egg indicated the better availability of dietary Zn-L-SeMet compared
to sodium selenite. The selenium content per egg was nearly double in the Zn-L-SeMet groups at both
dietary levels when compared to the sodium selenite groups. No differences between selenium sources
and levels were obtained for the GPx activity in serum, however there was a clear and signiﬁcant
increase compared to control level.
Chantiratikul et al. (2008a) compared the effects of sodium selenite and Zn-L-SeMet on plasma
selenium concentration and glutathione peroxidase (GPx) activity in the red blood cells (RBC) of laying
hens. The supplementation rates were 0.3, 1.0 and 3.0 mg Se/kg feed from both additives. Plasma
selenium concentration statistically increased (p < 0.01) with increasing selenium levels. Plasma Se
concentration of hens receiving Zn-L-SeMet supplemented diets was higher (p < 0.05) than that of hens
Table 4: Cumulative data for feed intake, laying rate, egg weight and ratio feed to egg mass,
Serum GPx and selenium (24 hens per treatment), and selenium in eggs (all eggs pooled/
replicate) on day 59
Selenium supplemented
(mg/kg) 0
Na-selenite Availa®Se
0.2 0.3 0.2 0.3
Selenium content (mg/kg)(1) 0.03 0.20 0.31 0.23 0.35
Feed intake (g/hen per day) 113 113 113 114 111
Laying rate (%) 98.4 96.8 95.3 98.1 98.3
Egg weight (g) 60.7 61.2 59.9 60.0 59.3
Ratio feed to egg mass (kg/kg) 1.89a 1.91a 1.98b 1.91a 1.91a
Serum Se (ng/mL) 29c 150b 170ab 181a 195a
Egg Se (ng/g liquid egg) < 50 129d 157c 231b 333a
GPx (U/mL serum) 100b 1,398a 1,736a 1,570a 1,510a
(1): Analysed.
a,b,c: Different superscripts within a given row indicate statistical differences (p < 0.05).
35 Technical Dossier/Section IV/Annex_IV_4_2.
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receiving sodium selenite supplemented diets. The Se sources did not dramatically alter GPx activity in
RBC. However, GPx activity signiﬁcantly increased (p < 0.01) with increasing dietary selenium levels. In a
subsequent publication of the same study, the authors (Chantiratikul et al., 2008b) described the effects
of both additives on performance and egg selenium concentration in laying hens. Feed consumption/kg
egg, egg production, egg weight, Haugh units and eggshell thickness were not affected by sources and
levels of selenium (p > 0.05). Increasing level of dietary selenium signiﬁcantly increased (p < 0.05)
selenium content in eggs. Zn-L-SeMet markedly increased (p < 0.05) egg selenium concentrations as
compared with sodium selenite. The results indicated that the use of Zn-L-SeMet resulted in higher
(p < 0.05) egg selenium concentrations than that of sodium selenite.
3.3.3. Conclusions on efﬁcacy for the target species
Zn-L-SeMet is an effective source of selenium in chickens for fattening and laying hens; this
conclusion is extended to all animal species.
3.4. Post-market monitoring
The FEEDAP Panel considers that there is no need for speciﬁc requirements for a post-market
monitoring plan other than those established in the Feed Hygiene Regulation36 and Good
Manufacturing Practice.
4. Conclusions
Zn-L-SeMet is a safe source of selenium for chickens for fattening; the conclusion is extended to all
animal species.
Selenium from Zn-L-SeMet does not elicit any adverse effects not expected for a selenium
compound. The use of Zn-L-SeMet in animal nutrition is expected to result in a similar increase in
selenium deposition in animal tissues/products as that resulting from other sources of SeMet. The use
of the additive is safe for consumers provided that the maximum selenium supplementation level
established for other sources of organic selenium (0.2 mg/kg complete feed) and that the maximum
authorised total selenium content (0.5 mg/kg complete feed) are respected.
The additive is hazardous upon inhalation; owing to the high dusting potential, persons handling
Availa®Se are at risk by inhalation. Availa®Se is not an irritant to the skin. In the absence of data, no
conclusion on the eye irritation and skin sensitisation can be drawn.
The use of Zn-L-SeMet in feed does not pose an additional risk to the environment, compared with
other sources of selenium for which it will substitute, as long as the maximum authorised content in
complete feed is not exceeded.
Zn-L-SeMet is an effective source of selenium in chickens for fattening and laying hens; this
conclusion is extended to all animal species.
The maximum contribution of zinc in total feed deriving from the use of the additive (< 0.2 mg Zn/kg
feed) is considered low and does not need any safety assessment except for users.
5. Recommendation
The additive, either as Zn-L-SeMet or as the formulated additive containing Zn-L-SeMet (i.e.
Availa®Se 1000), should be added to feed via premixture to ensure homogeneous distribution in
complete feed.
Documentation provided to EFSA
1) Zinc-L-selenomethionine (Availa Se). August 2016. Submitted by Zinpro Animal Nutrition
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4) Evaluation report of the European Union Reference Laboratory for Feed Additives on the
Methods(s) of Analysis for zinc-L-selenomethionine.
5) Comments from Member States.
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Annex A – Executive Summary of the Evaluation Report of the European
Union Reference Laboratory for Feed Additives on the Method(s) of
Analysis for zinc-L-selenomethionine
In the current application authorisation is sought under article 4(1) for Zinc-L-selenomethionine
under the category/functional group (3b) “nutritional additives”/“compounds of trace elements”,
according to the classiﬁcation system of Annex I of Regulation (EC) No 1831/2003. Speciﬁcally,
authorisation is sought for the use of the feed additive for all animal species and categories.
The feed additive (Zinc-L-selenomethionine) is a complexation product of zinc chloride and L-
selenomethionine containing about 63% of L-selenomethionine and about 20% of zinc. It is to be
marketed as a solid preparation, containing a minimum of 0.36% of Zinc-L-selenomethionine, which
corresponds to a minimum of 0.1% of selenium and 0.05% of zinc; it also contains calcium carbonate,
silicon dioxide and vegetable oil as carriers. The feed additive is intended to be incorporated into
feedingstuffs through premixtures with a proposed maximum total selenium content of 0.5 mg/kg
feedingstuffs to comply with legal requirements.
For the quantiﬁcation of Selenomethionine in the feed additive the Applicant submitted a single-
laboratory validated and further veriﬁed method based on high performance liquid chromatography
with ﬂuorescence detection (HPLC-FLD) after pre-column derivatisation with ortho-phthalaldehyde
(OPA). Based on the acceptable performance characteristics presented the EURL recommends for
ofﬁcial control this HPLC-FLD method to quantify Selenomethionine in the feed additive.
For the quantiﬁcation of total selenium in the feed additive the Applicant submitted the ofﬁcial
AOAC 2006.03 method designed for the analysis of elements in fertilisers, based on microwave
digestion with nitric acid followed by inductively coupled plasma-optical emission spectrometry (ICP-
OES). In the frame of other dossiers related to selenium containing feed additives the EURL evaluated
several alternative single-laboratory validated and further veriﬁed methods, and recommended for
ofﬁcial control either inductively coupled plasma-atomic emission spectrometry (ICP-AES), or
inductively coupled plasma-mass spectrometry (ICP-MS) for the quantiﬁcation of total selenium in the
feed additive.
For the quantiﬁcation of total selenium in premixtures and feedingstuffs the Applicant did not
propose any method for ofﬁcial control. However, the EURL previously evaluated and recommended
the CEN method EN 16159:2012 based on hydride generation atomic absorption spectrometry
(HGAAS) after microwave digestion with HNO3/H2O2. For the quantiﬁcation of total selenium in
premixtures, the EURL suggests diluting the premixtures samples with ground cereal feed and applying
the HGAAS method mentioned above. Based on the performance characteristics available, the EURL
recommends for ofﬁcial control the CEN method EN 16159:2012 for the quantiﬁcation of total selenium
in premixtures and feedingstuffs.
For the quantiﬁcation of total zinc in the feed additive, premixtures and feedingstuffs the Applicant
submitted the internationally recognised ring-trial validated method EN 15510 based on inductively
coupled plasma-atomic emission spectrometry (ICP-AES). Two additional ring-trial validated methods
were previously evaluated by the EURL in the frame of the Zinc group dossiers: EN 15621 based on
ICP-AES after pressure digestion and the Community method based on atomic absorption
spectrometry (AAS). Based on the performance characteristics available the EURL recommends for the
ofﬁcial control these two CEN methods for the quantiﬁcation of total zinc in the feed additive.
Further testing or validation of the methods to be performed through the consortium of National
Reference Laboratories as speciﬁed by Article 10 (Commission Regulation (EC) No 378/2005) is not
considered necessary.
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